Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

PEPSICO INC (PEP)

CIK 0000077476 2 material events

Insider activity (SEC Form 4)

Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.

Open-market · last 30 days: 0 buyers bought $0 0 sellers sold $0
Open-market · last 90 days: 0 buyers bought $0 1 seller sold $405K
InsiderRoleDateTransactionSharesValue
POHLAD ROBERT C Director 2026-08-06 J 900000 $0
POHLAD ROBERT C Director 2026-08-06 J 79731 $0
POHLAD ROBERT C Director 2026-08-05 Grant/award 398
Krishnan Ramkumar CEO, North America 2026-08-03 J 5688
Krishnan Ramkumar CEO, North America 2026-08-03 J 5688
Krishnan Ramkumar CEO, North America 2026-08-03 J 1320
Krishnan Ramkumar CEO, North America 2026-08-03 J 1320
Flavell David EVP, Gen Counsel & Corp Sec 2026-07-27 Open-market sell 2900 $405K
Willemsen Eugene CEO, International Beverages 2026-07-01 Grant/award 809 $0
Willemsen Eugene CEO, International Beverages 2026-07-01 Grant/award 540 $0
Bailey Jennifer Director 2026-06-01 Grant/award 424 $60K
Diamond Susan M Director 2026-06-01 Grant/award 565 $80K
Gibbs David W Director 2026-06-01 Grant/award 71 $10K
VASELLA DANIEL Director 2026-06-01 Grant/award 424 $60K
Bailey Jennifer Director 2026-05-31 Grant/award 125
Diamond Susan M Director 2026-05-31 Grant/award 128
VASELLA DANIEL Director 2026-05-31 Grant/award 1481
Gibbs David W Director 2026-05-06 Grant/award 1000 $0
Gibbs David W Director 2026-05-06 Grant/award 534 $0
Willemsen Eugene CEO, International Beverages 2026-03-04 Open-market sell 3798 $625K
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.

Risk Radar (year-over-year Risk Factors)

← All Risk Radar

Fiscal period ending 2025-12-27 versus 2024-12-28view filing on EDGAR →

Risk exposure broadened materially across regulatory, competitive, and operational dimensions, with no offsetting easing. The most acute near-term pressures are the near-doubling of Mexico's beverage tax (effective Jan 2026), confirmed tariff cost impacts on supply chain, and an expanded litigation profile now naming health-related product claims and shareholder actions. Worsening is pervasive but stops short of solvency or existential risk, placing the overall shift at moderate.

4 company-specific · 5 common-mode

Company-specific changes

Revised

Mexico tax rate nearly doubled (0.09 to 0.17 per liter), effective Jan 2026. Concrete escalation of existing tax burden materially worsens cost exposure.

Legal, Tax and Regulatory Risks Taxes aimed at our products can adversely affect our business or financial performance. Certain jurisdictions in which our products are sold have either imposed, or…

Revised

Added explicit risk that strategy may not be effective and failure to achieve announced 2025 commercial/financial priorities, signaling competitive and execution concerns.

Any inability to compete effectively can adversely affect our business. Our products compete against products of international beverage and convenient food companies that, like us, operate in…

Revised

Texas enacted new warning label law effective 2027 for artificial colors. Escalates regulatory burden and compliance costs across additional jurisdictions.

Limitations on the marketing or sale of our products can adversely affect our business and financial performance. Certain jurisdictions in which our products are sold have either imposed, or are…

Revised

Added specific disclosure of health-related product litigation and regulatory scrutiny, plus shareholder actions. Escalates from generic litigation risk to named substantive legal exposure.

Potential liabilities and costs from litigation, claims, legal or regulatory proceedings, inquiries or investigations can have an adverse impact on our business. We and our subsidiaries have been…

Also disclosed — common-mode (Tariffs trade policy ×2, Geopolitical macro uncertainty, ESG regulatory divergence, Data privacy regulation)
Tariffs trade policy Revised

New specific risks added: tariffs, SNAP funding restrictions, AI shopping agents, GLP-1 drugs, away-from-home consumption, regulatory scrutiny. Materially expands demand headwinds.

Business Risks Reduction in future demand for our products would adversely affect our business. Demand for our products depends in part on our ability to innovate and anticipate and effectively…

Tariffs trade policy Revised

Tariff risk elevated from conditional/illustrative to active impact statement. New language confirms tariffs "have impacted" and "could continue to impact" supply chain with increased costs, replacing prior speculative framing.

Disruption of our manufacturing operations or supply chain, including increased commodity, packaging, transportation, labor and other input costs, can adversely affect our business. We have…

Geopolitical macro uncertainty Revised

Added Venezuela intervention and EU tariffs; expanded SNAP subsidy risk. Escalates geopolitical and regulatory exposure.

Political, social and geopolitical conditions can adversely affect our business. The impact from political, social and geopolitical conditions in the markets in which our products are sold has been…

ESG regulatory divergence Revised

Shift from general EPR discussion to specific U.S. state implementation with concrete cost impact (fees to governments), escalating regulatory risk materiality.

Laws and regulations related to the use or disposal of plastics or other packaging materials can adversely affect our business and financial performance. We rely on diverse packaging solutions to…

Data privacy regulation Revised

New disclosure of AI-driven regulatory risk: data protection authorities adopting evolving privacy interpretations with specific obligations regarding personal data processing.

Failure to comply with personal data protection and privacy laws can adversely affect our business. We are subject to a variety of continuously evolving and developing laws and regulations in…

Material year-over-year changes to this company's Risk Factors (Item 1A), found by comparing each annual report to the prior year, judged for materiality, and classified as company-specific or common-mode against the cross-company catalog. Common-mode changes are the macro themes many companies disclose in common; they are collapsed above. A filing marked unchanged had no material change from the prior year; its summary describes the company's standing risks, which remain in force. Fiscal periods are the reporting period ends. Not investment advice.

Earnings release

8-K filed 2026-07-09 confidence 99% Item 2.02

This is a clear earnings release disclosing PepsiCo's second-quarter and year-to-date 2026 financial results. The Item 2.02 filing includes a press release dated July 9, 2026, reporting net revenue of $24.181 billion (Q2) and $43.624 billion (YTD), with detailed operating profit, EPS, and segment performance metrics. The filing also includes condensed consolidated financial statements and updated 2026 guidance, which are material to investors assessing the company's financial performance and outlook.

View raw filing on EDGAR →

Other material

8-K filed 2026-05-22 confidence 75% Item 8.01

PepsiCo terminated and replaced two material credit facilities totaling $10 billion ($5B 364-day and $5B five-year revolving credit agreements). While routine credit facility renewals are common, the disclosure of these $5 billion facilities and their replacement terms is material to investors assessing the company's liquidity and financing capacity. This does not fit neatly into the more specific event categories (not a covenant breach, not a going-concern issue, not M&A activity), making "other_material" the most appropriate classification.

View raw filing on EDGAR →